112 related articles for article (PubMed ID: 17637809)
21. IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.
Levesque MC; Misukonis MA; O'Loughlin CW; Chen Y; Beasley BE; Wilson DL; Adams DJ; Silber R; Weinberg JB
Leukemia; 2003 Feb; 17(2):442-50. PubMed ID: 12592345
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
[TBL] [Abstract][Full Text] [Related]
23. Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia.
Johnston JB; Kabore AF; Strutinsky J; Hu X; Paul JT; Kropp DM; Kuschak B; Begleiter A; Gibson SB
Oncogene; 2003 Nov; 22(51):8356-69. PubMed ID: 14614459
[TBL] [Abstract][Full Text] [Related]
24. The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill.
Pepper CJ; Hambly RM; Fegan CD; Delavault P; Thurston DE
Cancer Res; 2004 Sep; 64(18):6750-5. PubMed ID: 15374993
[TBL] [Abstract][Full Text] [Related]
25. Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications.
Crompot E; Van Damme M; Pieters K; Vermeersch M; Perez-Morga D; Mineur P; Maerevoet M; Meuleman N; Bron D; Lagneaux L; Stamatopoulos B
Haematologica; 2017 Sep; 102(9):1594-1604. PubMed ID: 28596280
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells.
Gehrke I; Gandhirajan RK; Poll-Wolbeck SJ; Hallek M; Kreuzer KA
Mol Med; 2011; 17(7-8):619-27. PubMed ID: 21519633
[TBL] [Abstract][Full Text] [Related]
27. Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells.
Lagneaux L; Delforge A; De Bruyn C; Bernier M; Bron D
Leuk Lymphoma; 1999 Nov; 35(5-6):445-53. PubMed ID: 10609782
[TBL] [Abstract][Full Text] [Related]
28. Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.
Lagneaux L; Delforge A; Bron D; De Bruyn C; Stryckmans P
Blood; 1998 Apr; 91(7):2387-96. PubMed ID: 9516138
[TBL] [Abstract][Full Text] [Related]
29. EphrinA4 plays a critical role in α4 and αL mediated survival of human CLL cells during extravasation.
Flores MA; Fortea P; Trinidad EM; García D; Soler G; Ortuño FJ; Zapata AG; Alonso-Colmenar LM
Oncotarget; 2016 Jul; 7(30):48481-48500. PubMed ID: 27374180
[TBL] [Abstract][Full Text] [Related]
30. Green tea polyphenol "epigallocatechin-3-gallate", differentially induces apoptosis in CLL B-and T-Cells but not in healthy B-and T-Cells in a dose dependant manner.
Cornwall S; Cull G; Joske D; Ghassemifar R
Leuk Res; 2016 Dec; 51():56-61. PubMed ID: 27855324
[TBL] [Abstract][Full Text] [Related]
31. Differential effects on CLL cell survival exerted by different microenvironmental elements.
Ghia P; Circosta P; Scielzo C; Vallario A; Camporeale A; Granziero L; Caligaris-Cappio F
Curr Top Microbiol Immunol; 2005; 294():135-45. PubMed ID: 16323430
[TBL] [Abstract][Full Text] [Related]
32. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro.
Panayiotidis P; Jones D; Ganeshaguru K; Foroni L; Hoffbrand AV
Br J Haematol; 1996 Jan; 92(1):97-103. PubMed ID: 8562418
[TBL] [Abstract][Full Text] [Related]
33. Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: any role for Notch, Wnt and Hh signaling pathways?
Seke Etet PF; Vecchio L; Nwabo Kamdje AH
Cell Signal; 2012 Jul; 24(7):1433-43. PubMed ID: 22446006
[TBL] [Abstract][Full Text] [Related]
34. Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironment.
Schulz A; Dürr C; Zenz T; Döhner H; Stilgenbauer S; Lichter P; Seiffert M
Blood; 2013 Mar; 121(13):2503-11. PubMed ID: 23349394
[TBL] [Abstract][Full Text] [Related]
35. Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance.
Kurtova AV; Balakrishnan K; Chen R; Ding W; Schnabl S; Quiroga MP; Sivina M; Wierda WG; Estrov Z; Keating MJ; Shehata M; Jäger U; Gandhi V; Kay NE; Plunkett W; Burger JA
Blood; 2009 Nov; 114(20):4441-50. PubMed ID: 19762485
[TBL] [Abstract][Full Text] [Related]
36. [Use of Porous Hydrogel as a 3D Scaffold for the Growth of Leukemic B Lymphocytes].
Studená R; Horák D; Baloun J; Plichta Z; Pospíšilová Š
Klin Onkol; 2017; 30(Supplementum1):184-186. PubMed ID: 28471202
[TBL] [Abstract][Full Text] [Related]
37. Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo.
Seiffert M; Schulz A; Ohl S; Döhner H; Stilgenbauer S; Lichter P
Blood; 2010 Nov; 116(20):4223-30. PubMed ID: 20660791
[TBL] [Abstract][Full Text] [Related]
38. Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".
Kay NE; Shanafelt TD; Strege AK; Lee YK; Bone ND; Raza A
Leuk Res; 2007 Jul; 31(7):899-906. PubMed ID: 17241660
[TBL] [Abstract][Full Text] [Related]
39. A novel method to investigate drug resistance in the chronic lymphocytic leukemia (CLL) microenvironment: Analysis of CLL Cellular Environment and Response (ACCER).
Choquette T; Henson ES; Yang X; Johnston JB; Gibson SB
Leuk Lymphoma; 2023 Apr; 64(4):822-834. PubMed ID: 36803637
[TBL] [Abstract][Full Text] [Related]
40. Optimizing the process of nucleofection for professional antigen presenting cells.
Mullins CS; Wegner T; Klar E; Classen CF; Linnebacher M
BMC Res Notes; 2015 Sep; 8():472. PubMed ID: 26404473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
